Transmucosal Fentanyl
Transmucosal Fentanyl is a pharmaceutical formulation of fentanyl designed for rapid absorption through mucosal membranes, distinguished from other opioid delivery methods by its targeted use in the management of breakthrough cancer pain via non-invasive, mucoadhesive administration routes such as buccal, sublingual, or nasal mucosa.
113
Publications
7.8K
Citations
463
Authors
246
Institutions
Publications per year
2017–2026
12
Parents
113
Defining the clinically important difference in pain outcome measures
John T. Farrar, Russell K. Portenoy, Jesse A. Berlin et al. · Pain · 2000 · 1.1K citations
Absorption and Bioavailability of Oral Transmucosal Fentanyl Citrate
James B. Streisand, John R. Varvel, Donald R. Stanski et al. · Anesthesiology · 1991 · 248 citations · Full text
John T. Farrar, James F. Cleary, Richard Rauck et al. · JNCI Journal of the National Cancer Institute · 1998 · 247 citations · Full text
Medicine, Pharmacotherapy, Surgery +17
1–5 of 113
463
10
h-index
10
h-index
9
h-index
8
h-index
8
h-index
1–5 of 463
246
University of Utah
Salt Lake City, United States
14 h-index
80 publications
5.2K citations
La Maddalena
Palermo, Italy
8 h-index
14 publications
942 citations
Yale University
New Haven, United States
4 h-index
4 publications
673 citations
University of Washington
Seattle, United States
4 h-index
12 publications
848 citations
American Society of Anesthesiologists
Schaumburg, United States
4 h-index
30 publications
1.3K citations

Mount Sinai Beth Israel
New York, United States
4 h-index
10 publications
1.8K citations
University of Pennsylvania
Philadelphia, United States
3 h-index
7 publications
4.6K citations
Memorial Sloan Kettering Cancer Center
New York, United States
3 h-index
6 publications
936 citations
1–8 of 246
12 publications · 639 citations
12
h-index
9 publications · 692 citations
9
h-index
6 publications · 2K citations
6
h-index
Repository · 6 publications · 220 citations
6
h-index
5 publications · 154 citations
5
h-index
1–5